plerixafor has been researched along with Carcinoma, Intraepithelial in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baleux, F; Brule, S; Charnaux, N; Friand, V; Gattegno, L; Sutton, A | 1 |
1 other study(ies) available for plerixafor and Carcinoma, Intraepithelial
Article | Year |
---|---|
Glycosaminoglycans and syndecan-4 are involved in SDF-1/CXCL12-mediated invasion of human epitheloid carcinoma HeLa cells.
Topics: Anthracenes; Benzylamines; Carcinoma in Situ; Cell Movement; Chemokine CXCL12; Cyclams; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Glycosaminoglycans; HeLa Cells; Heterocyclic Compounds; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Signal Transduction; Syndecan-4; Uterine Cervical Neoplasms | 2009 |